§ Funding Round
Obsidian Therapeutics raised $160.5M Series C venture round, led by irina margine, ph.d..
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
Bristol Myers Squibb | — | — |
| Organization | — | |
| Organization | — | |
Janus Henderson Investors | — | — |
Logos Capital | — | — |
| Angel | ray camahort | |
Paradigm BioCapital | — | — |
| Organization | — | |
| Organization | — | |
Samsara BioCapital | — | — |
Surveyor Capital | — | — |
TCGX | — | — |
T. Rowe Price Associates | — | — |
| Angel | irina margine, ph.d. | |
| Organization | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$330.5M
Top Valuation
-
Obsidian Therapeutics raised $160.5M in a Series C round.
The round was announced on 04/03/24.
The round was led by irina margine, ph.d..
